Regulation of Genome Editing in Human iPS Cells A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies /
| Údar corparáideach: | |
|---|---|
| Rannpháirtithe: | , |
| Achoimre: | X, 334 p. 13 illus., 10 illus. in color. text |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Cham :
Springer International Publishing : Imprint: Springer,
2022.
|
| Eagrán: | 1st ed. 2022. |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1007/978-3-030-93023-3 |
| Formáid: | Leictreonach LEABHAR |
Clár na nÁbhar:
- Introduction
- Biological Aspects of Genome Editing in iPS Cells
- Ethical Aspects in the Context of Genome Editing
- Regulation of Genome Editing in iPS Cells: Germany
- Regulation of Genome Editing in iPS Cells: France
- Regulation of Genome Editing in iPS Cells: Switzerland
- Regulation of Genome Editing in iPS Cells: United States
- Regulation of Genome Editing in iPS Cells: Japan
- Regulation of Genome Editing in iPS Cells: Republic of Korea
- Comparative Analysis.